The initial tumor of Case 4 may have been a lower-grade astrocytoma, not a GBM, at initial diagnosis, and it may have subsequently harbored CDKN2A/B homozygous deletions at recurrence 10 months after the first surgery. This evidence concerns the gene CDKN2A and astrocytoma (excluding glioblastoma).